Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Johnson & Johnson (NYSE:JNJ)

125.48
Delayed Data
As of Mar 24
 -0.42 / -0.33%
Today’s Change
107.69
Today|||52-Week Range
129.00
+8.91%
Year-to-Date
Can This Pharma Stock Withstand the 'Trump Effect'?
Mar 25 / TheStreet.com - Paid Partner Content
4 Biotech Stocks to Watch
Mar 22 / GuruFocus News - Paid Partner Content
The Threat and Risk of Rising Interest Rates: Separating Fact From Fiction
Mar 24 / GuruFocus News - Paid Partner Content
5 Excellent ETFs for Your IRA
Mar 20 / Zacks.com - Paid Partner Content
Can the Repeal of the Fiduciary Rule Harm Your Annuities Investments?
Mar 24 / TheStreet.com - Paid Partner Content
What You Need to Know About the March Rate Hike
Mar 20 / GuruFocus News - Paid Partner Content
Pharma Stock Roundup: Is Sanofi Buying Flexion? Pfizer, Merck KGaA Drug Approved
Mar 24 / Zacks.com - Paid Partner Content
Will Apple Be the Next AAA-Rated Company?
Mar 20 / GuruFocus News - Paid Partner Content
Frontrunning: March 24
Mar 24 / Investing Channel - Paid Partner Content
Trumpcare may be healthy for Big Pharma and insurers
Mar 20 / CNNMoney.com
Why Google Has to Definitively Address Its Offensive Content Problem
Mar 23 / TheStreet.com - Paid Partner Content
Compound Interest Is Real Modern-Day Alchemy
Mar 19 / GuruFocus News - Paid Partner Content
Google's Latest Content Controversy Is Messy, But Fixable
Mar 23 / TheStreet.com - Paid Partner Content
Pharma Stock Roundup: AstraZeneca's Lynparza Impresses in Study, Merck Drug Label Exp...
Mar 17 / Zacks.com - Paid Partner Content
Johnson & Johnson Latest to Pull Ads From YouTube
Mar 23 / TheStreet.com - Paid Partner Content
Pfizer's Arthritis Drug Xeljanz Gets Marketing Nod in China
Mar 16 / Zacks.com - Paid Partner Content
Catalyst Pharma (CPRX) Focused on U.S. Approval for Firdapse
Mar 23 / Zacks.com - Paid Partner Content
3 Big Pharma Stocks To Buy in Your 401(k)
Mar 12 / MotleyFool.com - Paid Partner Content
These 3 Would Look Great at Lower Prices
Mar 23 / TheStreet.com - Paid Partner Content
The 3 Most Important Numbers for Johnson & Johnson
Mar 12 / MotleyFool.com - Paid Partner Content
Investing Your Tax Refund Now Delivers Greater Returns
Mar 23 / TheStreet.com - Paid Partner Content
How to drink wine without removing the cork
Mar 10 / CNNMoney.com
AT&T & Verizon Suspend Marketing Advertisements from YouTube
Mar 23 / Zacks.com - Paid Partner Content
Johnson & Johnson to cut 400 jobs in Scotland
Mar 09 / FT.com - Paid Partner Content
Frontrunning: March 24
Mar 23 / Investing Channel - Paid Partner Content
Trump's pledge on drug pricing squeezes pharma stocks
Mar 07 / FT.com - Paid Partner Content
AT&T and Verizon halt Google ads over extremist videos
Mar 22 / CNNMoney.com
J&J's legal costs surge in wave of product lawsuits
Mar 07 / FT.com - Paid Partner Content
MedTech Long-Term Prospects Impress: Which Stocks to Buy?
Mar 22 / Zacks.com - Paid Partner Content